Lumella point-of-care test for assessing pre-eclampsia risk

  • Medtech innovation briefing
  • MIB287
  • Published: 
Download (PDF)

Regulatory information

The Lumella test is CE‑marked as an in vitro diagnostic medical device (In Vitro Diagnostic Directive; general category).